Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY
Stopped The study was closed to accrual according to the Fred Hutch/University of Washington/Seattle Children's Consortium low accrual institutional policy.
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Solid Neoplasm
Interventions
- DRUG: Nozin
- OTHER: Best Practice
Sponsor
Fred Hutchinson Cancer Center
Collaborators